In the 1990s several big pharmaceutical firms, including Bayer(nyse: BAY - news - people ) AG of Germany, Eli Lilly and Pfizer, formed alliances with Chinese research institutes or companies that specialized in traditional Chinese medicines, aiming to apply modern drug-hunting techniques to screen Chinese herbal medicines for potential Western blockbusters.